Jon Soderstrom will step down as managing director of Yale University’s tech transfer office tomorrow after 25 years in the job.

The Stanford spinout has gone public following a $238m IPO, after revealing that the university was also among the series B investors.

Partly based on research at University of Washington, KenSci has agreed to an acquisition by Tegria for an undisclosed sum.

The Asahi Kasei and Shenzhen Hepalink-backed microbial detection system provider has amassed over $340m of funding before filing for an initial public offering.

The cancer drug developer is set to float on the Nasdaq Global Select Market, presenting an opportunity for strategic investors Pharmaron, Celgene, Amgen and Merck & Co to exit.

Gree's GFR Fund helped the virtual reality platform close a series D round which will support expansion and the development of new features including a creator economy.

Juniper Networks, Wargaming and CME Group have exited secure communications app developer Wickr in an acquisition by AWS while Country Garden reinvested in tea producer Chali.

SoftBank, Hearst and NBCUniversal-backed digital media company will get a Nasdaq listing through the deal, valuing it just below its last funding round five years ago.

Third Rock Ventures has led a series A round for Abata Therapeutics that also featured fellow existing investor ElevateBio.

Third Rock Ventures has led a series A round for Abata Therapeutics, launched by the firm to commercialise research from Harvard, MIT, Johns Hopkins, NIH and UZH.